Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
3,846,145
-
Share change
-
+498,799
-
Total reported value
-
$39,529,000
-
Price per share
-
$10.26
-
Number of holders
-
20
-
Value change
-
+$5,078,502
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) as of Q2 2019
As of 30 Jun 2019,
REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,846,145 shares.
The largest 10 holders included
MIZUHO SECURITIES USA LLC, OxFORD Asset Management LLP, Karpus Management, Inc., BANK OF AMERICA CORP /DE/, BANK OF MONTREAL /CAN/, Periscope Capital Inc., BOOTHBAY FUND MANAGEMENT, LLC, Shaolin Capital Management LLC, GABELLI & Co INVESTMENT ADVISERS, INC., and COWEN INC..
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.